Teledyne FLIR Defense Unveils Multiple Upgrades to Black Hornet 4 Nano-Drone at SOF Week
Fifty percent greater comms range and easier-to-use Android tablet with twice the battery life are some of new user-driven features on Black Hornet unmanned aerial... Read more.
Kolibri Global Energy Inc. Announces Lovina Wells Drilled 25% Faster Than the Previous 1.5 Mile Lateral Wells
THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Kolibri Global Energy Inc. (the “Company” or “Kolibri”) (TSX: KEI, NASDAQ: KGEI) is pleased to provide... Read more.
TELUS Digital Expands Partnership with Sumsub to Deliver End-to-End Identity Verification and Fraud Prevention Solutions
Companies implementing ID verification and fraud prevention capabilities can experience cost savings and revenue increases Expanded offering supports TELUS Digital... Read more.
MarketAxess Reports First Quarter 2025 Financial Results
EPS of $0.40; $1.87 Excluding Notable Items1 Record Total ADV Driven by Record Credit ADV with Record Open Trading ADV of $4.8 billion Record Total Portfolio Trading... Read more.
Cencora Reports Fiscal 2025 Second Quarter Results
Revenue of $75.5 billion for the Second Quarter, a 10.3 percent Increase Year-Over-Year Second Quarter GAAP Diluted EPS of $3.68 and Adjusted Diluted EPS of $4.42... Read more.
RXO Announces First-Quarter Results, Successful Migration of Coyote Coverage Operations to the RXO Connect® Platform
Carrier and coverage operations now occurring in one unified system, enabling future cost-of-purchased-transportation synergies. Raising synergy estimate; now expect... Read more.
NiSource Announces First Quarter Results
Reaffirming 2025 non-GAAP adjusted EPS guidance Reaffirming expected annual 6%-8% 2025-2029 non-GAAP adjusted EPS growth MERRILLVILLE, Ind.–(BUSINESS WIRE)–NiSource... Read more.
Trane Technologies to Present at the Wolfe Research Global Transportation and Industrials Conference
SWORDS, Ireland–(BUSINESS WIRE)–Trane Technologies plc (NYSE: TT) a global climate innovator, today announced that company leadership will participate... Read more.
Marea Therapeutics Presents Positive Data from Phase 2a Clinical Trial of MAR001, Being Developed for Cardiovascular Disease, in Late-Breaking Oral Session at the 93rd EAS Congress
MAR001, a first-in-class monoclonal antibody targeting ANGPTL4, demonstrated approximately 53% placebo-adjusted mean reduction in remnant cholesterol and placebo-adjusted... Read more.
The GEO Group Reports First Quarter 2025 Results
BOCA RATON, Fla.–(BUSINESS WIRE)–The GEO Group, Inc. (NYSE: GEO) (“GEO”), a leading provider of contracted support services for secure facilities,... Read more.